DUOPHARMA BIOTECH BERHAD

KLSE: 7148 (DPHARMA)

Kemas kini terakhir: 6 minit lalu

1.24

-0.01 (-0.80%)

  • 1H -0.80%
  • 5H -0.80%
  • 1B -2.36%
  • 6B -10.14%
  • Tahun Ke Tarikh -1.59%
  • 1T -3.13%
  • 5T -56.61%
Penutupan Terdahulu 1.25
Buka 1.25
Jumlah Dagangan 117,400
Purata Dagangan (3B) 495,580
Modal Pasaran 1,192,808,704
Harga / Pendapatan (P/E TTM) 13.78
Harga / Pendapatan (P/E Ke hadapan) 12.35
Harga / Jualan (P/S) 1.35
Harga / Buku (P/B) 1.63
Julat 52 Minggu
1.07 (-13%) — 1.46 (17%)
Tarikh Pendapatan 13 Aug 2025 - 18 Aug 2025
Hasil Dividen (DY TTM) 2.82%
Margin Keuntungan 8.26%
Margin Operasi (TTM) 14.69%
EPS Cair (TTM) 0.080
Pertumbuhan Hasil Suku Tahunan (YOY) 36.20%
Pertumbuhan Pendapatan Suku Tahunan (YOY) 67.80%
Jumlah Hutang/Ekuiti (D/E MRQ) 70.73%
Nisbah Semasa (MRQ) 3.83
Aliran Tunai Operasi (OCF TTM) 114.27 M
Aliran Tunai Bebas Leveraj (LFCF TTM) 53.91 M
Pulangan Atas Aset (ROA TTM) 5.22%
Pulangan Atas Ekuiti (ROE TTM) 10.48%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Drug Manufacturers - Specialty & Generic (MY) Bercampur Bercampur
Drug Manufacturers - Specialty & Generic (Global) Menaik Bercampur
Stok DPHARMA Menaik Menaik

AISkor Stockmoo

-0.3
Konsensus Penganalisis 5.0
Aktiviti Orang Dalam NA
Volatiliti Harga -2.0
Purata Bergerak Teknikal -3.5
Osilator Teknikal -0.5
Purata -0.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
DPHARMA 1 B 2.82% 13.78 1.63
KOTRA 620 M 3.11% 14.41 2.15
YSPSAH 298 M 5.24% 12.35 0.740
RHONEMA 144 M 1.53% 16.38 0.840
PLABS 69 M - 25.00 0.890

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
Sektor Healthcare
Industri Drug Manufacturers - Specialty & Generic
Gaya Pelaburan Small Value
% Dimiliki oleh Orang Dalam 2.64%
% Dimiliki oleh Institusi 71.87%

Pemilikan

Nama Tarikh Syer Dipegang
Billion Victory Sdn Bhd 31 Mar 2023 15,070,000 (1.57%)
Manulife Investment Shariah Progress Fund 31 Oct 2022 8,670,000 (0.90%)
Julat 52 Minggu
1.07 (-13%) — 1.46 (17%)
Julat Harga Sasaran
1.60 (29%) — 1.70 (37%)
Tinggi 1.70 (TA, 37.10%) Beli
Median 1.65 (33.07%)
Rendah 1.60 (RHB, 29.03%) Beli
Purata 1.65 (33.07%)
Jumlah 2 Beli
Harga Purata @ Panggilan 1.28
Syarikat Tarikh Harga Sasaran Panggilan Harga @ Panggilan
RHB 25 Nov 2025 1.60 (29.03%) Beli 1.27
14 Nov 2025 1.60 (29.03%) Beli 1.28
TA 14 Nov 2025 1.70 (37.10%) Beli 1.28

Tiada data dalam julat masa ini.

  • 3M
Tarikh Jenis Butiran
25 Nov 2025 TheEdge Apex Healthcare privatisation piques interest
14 Nov 2025 TheEdge Genting, OCK, Citaglobal, Pharmaniaga, Duopharma, Calrsberg, Dutch Lady, S P Setia, GuocoLand, Hume Cement, Mi Technovation, Samaiden, Keyfield, AWC, Media Prima
13 Nov 2025 Pengumuman CHANGE IN THE COMPOSITION OF THE BOARD COMMITTEES OF DUOPHARMA BIOTECH BERHAD
13 Nov 2025 Pengumuman Change in Audit Committee - DR HASNITA BINTI HASHIM
13 Nov 2025 Pengumuman Change in Risk Committee - ENCIK MOHAMAD IDROS BIN MOSIN
13 Nov 2025 Pengumuman Change in Risk Committee - DATO' EISAH BINTI A. RAHMAN
13 Nov 2025 Pengumuman Change in Nomination and Remuneration Committee - DR HASNITA BINTI HASHIM
13 Nov 2025 Pengumuman Change in Nomination and Remuneration Committee - DATO' EISAH BINTI A.RAHMAN
13 Nov 2025 Pengumuman Change in Boardroom - DATUK WIRA ARHAM BIN ABDUL RAHMAN
13 Nov 2025 Pengumuman Change in Boardroom - DATO' EISAH BINTI A. RAHMAN
13 Nov 2025 Pengumuman Duopharma Biotech achieves strong profitability in Q3 FY2025
13 Nov 2025 Pengumuman Quarterly rpt on consolidated results for the financial period ended 30/09/2025
13 Nov 2025 Pengumuman Change in Audit Committee - DATO' ADNAN HISHAM BIN PAWANTEH
30 Oct 2025 Pengumuman MATERIAL LITIGATION
29 Oct 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
28 Oct 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
23 Oct 2025 TheEdge Cover Story - Budget 2026: Budget to spark sector rotation, sin stocks in the line of fire
09 Oct 2025 Pengumuman MATERIAL LITIGATION
06 Oct 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
03 Oct 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
30 Sep 2025 TheEdge Pharmaniaga’s shot at redemption lies in biopharma
23 Sep 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
23 Sep 2025 TheEdge Brokers Digest: Local Equities - Healthcare, Cahya Mata Sarawak Bhd, Uzma Bhd, ITMAX System Bhd
18 Sep 2025 TheEdge Cover Story: Corporate earnings show strength despite macro headwinds
11 Sep 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
09 Sep 2025 Pengumuman Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - EMPLOYEES PROVIDENT FUND BOARD
Papar semua
Hasil Dividen (DY TTM) 2.82%
Purata Hasil Dividen 5T 2.31%
Nisbah Pembayaran 39.53%
Jangkaan Pembayaran Dividen Seterusnya Mar 2026
Tarikh EX Tarikh Pengumuman Tarikh Pembayaran Perincian
08 Sep 2025 21 Aug 2025 24 Sep 2025 0.015 Tunai
05 Mar 2025 19 Feb 2025 19 Mar 2025 0.02 Tunai
29 Aug 2024 15 Aug 2024 12 Sep 2024 0.01 Tunai
07 Mar 2024 22 Feb 2024 21 Mar 2024 0.018 Tunai
08 Sep 2023 24 Aug 2023 22 Sep 2023 0.005 Tunai
07 Apr 2023 27 Mar 2023 09 May 2023 0.018 Tunai
29 Aug 2022 16 Aug 2022 14 Sep 2022 0.005 Tunai
14 Apr 2022 24 Mar 2022 13 May 2022 0.018 Tunai
30 Aug 2021 17 Aug 2021 15 Sep 2021 0.005 Tunai
21 Apr 2021 08 Apr 2021 21 May 2021 0.06 Tunai
28 Aug 2020 13 Aug 2020 11 Sep 2020 0.005 Tunai
13 Jul 2020 30 Jun 2020 12 Aug 2020 0.05 Tunai
15 Oct 2019 02 Oct 2019 14 Nov 2019 0.01 Tunai
26 Jun 2019 13 Jun 2019 26 Jul 2019 0.04 Tunai
02 Nov 2018 22 Oct 2018 23 Nov 2018 0.015 Tunai
13 Jun 2018 31 May 2018 17 Jul 2018 0.06 Tunai
17 Oct 2017 25 Aug 2017 10 Nov 2017 0.025 Tunai
26 May 2017 24 Feb 2017 23 Jun 2017 0.04 Tunai
19 Oct 2016 22 Aug 2016 11 Nov 2016 0.025 Tunai
06 Jun 2016 23 Feb 2016 28 Jun 2016 0.055 Tunai
13 Oct 2015 25 Aug 2015 06 Nov 2015 0.04 Tunai
27 May 2015 24 Feb 2015 25 Jun 2015 0.145 Tunai
15 Oct 2014 26 Aug 2014 07 Nov 2014 0.04 Tunai
22 May 2014 26 Feb 2014 20 Jun 2014 0.135 Tunai
14 Oct 2013 28 Aug 2013 08 Nov 2013 0.04 Tunai
14 Jun 2013 22 Mar 2013 12 Jul 2013 0.105 Tunai
15 Oct 2012 16 Aug 2012 09 Nov 2012 0.035 Tunai
06 Jun 2012 16 Mar 2012 29 Jun 2012 0.145 Tunai
05 Oct 2011 18 Aug 2011 28 Oct 2011 0.035 Tunai
08 Jun 2011 21 Apr 2011 27 Jun 2011 0.11 Tunai
06 Oct 2010 02 Sep 2010 28 Oct 2010 0.045 Tunai
09 Jun 2010 21 Apr 2010 25 Jun 2010 0.12 Tunai
01 Oct 2009 26 Aug 2009 23 Oct 2009 0.06 Tunai
10 Jun 2009 15 Apr 2009 26 Jun 2009 0.07 Tunai
08 Oct 2008 26 Aug 2008 28 Oct 2008 Interim Dividend
03 Oct 2007 24 Aug 2007 18 Oct 2007 Interim Dividend
29 May 2007 25 Apr 2007 08 Jun 2007 Final Dividend
11 Sep 2006 23 Aug 2006 22 Sep 2006 Interim Dividend
18 May 2006 24 Apr 2006 08 Jun 2006 First and Final Dividend
26 Jul 2005 06 Jun 2005 18 Aug 2005 Final Dividend
21 Oct 2004 06 Oct 2004 08 Nov 2004 Interim Dividend
06 Jul 2004 01 Jun 2004 28 Jul 2004 Final Dividend
26 Sep 2003 09 Sep 2003 20 Oct 2003 Interim Dividend
23 Jun 2003 25 Apr 2003 08 Jul 2003 First and Final Dividend
Papar semua

Hasil Dividen Tahunan

Tahun Dividen Tahunan ($) Kekerapan/Tahun Hasil %
2025 0.035 2 2.82
2024 0.028 2 2.24
2023 0.023 2 1.83
2022 0.023 2 1.43
2021 0.065 2 3.87
2020 0.055 2 2.17
2019 0.050 2 4.70
2018 0.075 2 10.53
2017 0.065 2 7.99
2016 0.080 2 12.57
2015 0.185 2 21.97
2014 0.175 2 29.38
2013 0.145 2 23.59
2012 0.180 2 35.47
2011 0.145 2 30.13
2010 0.165 2 28.97
2009 0.130 2 23.22
Papar semua

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda